Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Heli K. Patel"'
Autor:
Areesha A. Charania, Heli K. Patel, Zeenia Punjani, Zeelu H. Patel, Georgios Papachristou, Carlo M. Contreras, Allan Tsung, Karim I. Budhwani
Publikováno v:
Journal of Clinical Oncology. 40:e13501-e13501
e13501 Background: Nearly 70% of diagnostics lab test errors occur due to variability in preanalytical factors. Preanalytical factors comprise parameters from the time tissue is extracted from the patient to the time it is tested in the lab. For lack
Autor:
Zeenia Punjani, Zeelu H. Patel, Areesha A. Charania, Heli K. Patel, Georgios Papachristou, Carlo M. Contreras, Allan Tsung, Karim I. Budhwani
Publikováno v:
Journal of Clinical Oncology. 40:e13503-e13503
e13503 Background: Despite advances in high-throughput screening, combinatorial chemistry, databanks, and computational models, drug R&D remains expensive and slow, often over a decade. It is estimated that pre-human costs are > 30% of cost of approv
Autor:
Zeelu H. Patel, Areesha A. Charania, Zeenia Punjani, Heli K. Patel, Mary Kathryn Sewell-Loftin, Mansoor N. Saleh, Karim I. Budhwani
Publikováno v:
Journal of Clinical Oncology. 40:e13500-e13500
e13500 Background: Despite recent advances in therapeutics, cancer remains the second leading cause of death worldwide. Next generation cancer models hold the promise of breaking this stranglehold. However, extracting adequate tissue for precision an
Autor:
Heli K. Patel, Zeenia Punjani, Areesha A. Charania, Zeelu H. Patel, Georgios Papachristou, Carlo M. Contreras, Allan Tsung, Karim I. Budhwani
Publikováno v:
Journal of Clinical Oncology. 40:e13502-e13502
e13502 Background: Nearly half the world will be diagnosed with cancer. Each year, > 1.7 million new cancers are diagnosed in the US. Worse, systemic therapy turns out to be ineffective in 70% of patients because those drugs do not match the patient